CClinicalTrials.gg
CompletedNCT02886520Updated Jul 26, 2019

Comparative Study of PDVF and Polypropylene Transobturator Suburethral Tapes

A Phase 4 interventional study of PVDF transobturator tape and Polypropylene transobturator tape in Urinary Stress Incontinence, sponsored by Hospital Universitari Vall d'Hebron Research Institute. Completed at 9 sites in Spain. Open to female participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-07-26.

Sponsored by Hospital Universitari Vall d'Hebron Research Institute · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2016, registered Aug 2016).
Phase
Phase 4
Study type
Interventional
Enrollment
286
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
Female
01

Study summary

This study evaluates the effectiveness and complications of polyvinylidene fluoride (PVDF) and polypropylene (PP) transobturator suburethral tapes (TOTs) in the treatment of female stress urinary incontinence. Half of participants will be operated with PVDF-TOTs, while the other half will be operated with PP ones.

02

Conditions studied

  • Urinary Stress Incontinence

Keywords

  • Urinary incontinence
  • Materials
  • Surgery
  • Transobturator tape
  • Polyvinylidene fluoride
  • Polypropylene
03

In context

Urinary Incontinence, Stress

658 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

This study's enrollment of 286 is above the median of 70 across 509 interventional studies indexed under Urinary Incontinence, Stress.

Browse Urinary Incontinence, Stress studies →

Lead sponsor

Hospital Universitari Vall d'Hebron Research Institute is the lead sponsor of 268 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women with stress urinary incontinence.
  • Women with stress-predominant mixed urinary incontinence.

Exclusion criteria

Exclusion Criteria:

  • Incapacity to understand the information or give their consent.
  • Previous anti-incontinence surgery with slings.
  • Low pressure urethra (MUCP \< 20cmH2O).
  • Neurogenic bladder.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
286 participants (actual)

Study arms

  • Active comparator
    PVDF transobturator tape

    Transobturator tension-free suburethral tape made of polyvinylidene fluoride.

    Device: PVDF transobturator tape

  • Active comparator
    PP transobturator tape

    Transobturator tension-free suburethral tape made of polypropylene.

    Device: Polypropylene transobturator tape

Interventions

  • DevicePVDF transobturator tape

    Also known as: Dynamesh-SIS

  • DevicePolypropylene transobturator tape
06

What researchers measure

Primary outcomes

  1. Effectiveness

    Percentage of patients who are regarded as cured or improved one-year after surgery with both techniques based on the following criteria: * CURED: negative cough stress test and patient must be fully satisfied with the operation (no leaks, no voiding dysfunction, and no use of urinary protection); Patient Global Impresison of Improvement (PGI-I) scale must be "Very much better". * IMPROVED: cough stress test had to be negative and the patient moderately satisfied with the result of surgery due to an increase in urinary frequency and/or sporadic urgency episodes; PGI-I must be "Much better" or "A little better".

    Time frame: One year

Secondary outcomes

  1. Number of participants with adverse events

    Comparison of the intra- and postoperative complications between both procedures.

    Time frame: Up to one year.

Other outcomes

  1. Change in subjective questionnaires of incontinence severity

    Change in the punctuation of the following questionnaires comparing before surgery and one year after operation: * International consultation on Incontinence Urinary Questionnaire-Short Form (ICIQ-SF). * Sandvik severity index.

    Time frame: One year

07

Study locations

9 sites
  • Hospital de Mataró
    Barcelona, Spain
  • Hospital de Viladecans
    Barcelona, Spain
  • Hospital General de Granollers
    Barcelona, Spain
  • Hospital Universitari de Bellvitge
    Barcelona, Spain
  • Hospital Universitari Vall d'Hebron
    Barcelona, Spain
  • Hospital Santa Caterina
    Girona, Spain
  • Hospital General Riotinto
    Huelva, Spain
  • Hospital Quiron Sagrado Corazon
    Sevilla, Spain
  • Hospital Virgen del Rocío
    Sevilla, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02886520
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Collaborators
Hospital de Granollers, Hospital Quiron Sagrado Corazon, Hospital de Mataró, Hospital Riotinto, Hospitales Universitarios Virgen del Rocío, Hospital Universitari de Bellvitge, Hospital de Viladecans, Hospital Santa Caterina
Responsible party
Sponsor
First posted
Sep 1, 2016
Start date
Apr 2016
Primary completion
Apr 2019
Completion
Apr 2019
Last update
Jul 26, 2019

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion